Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
08.05.26
/
50%
€22.10
Target price
08.05.27
€36.67
Performance (%)
2.40%
Price
13.08.26
€22.77
Summary
This prediction is currently active. With a performance of 2.40%, the BUY prediction by Guggenheim for Ultragenyx Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 08.05.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.869% | -1.869% |
| iShares Core DAX® | 0,88 % | 5,63 % |
| iShares Nasdaq 100 | 2,39 % | 1,57 % |
| iShares Nikkei 225® | 4,27 % | 2,52 % |
| iShares S&P 500 | 1,17 % | 2,55 % |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (RARE) had its price target lowered by Guggenheim from $52.00 to $43.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.39
04.08.26
04.08.26
€30.41
04.08.27
04.08.27
2.68%
13.08.26
13.08.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€20.00
05.01.26
05.01.26
€44.47
05.01.27
05.01.27
14.95%
13.08.26
13.08.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-26.03%
21.06.26
21.06.26